Comment on "High-dose, high-frequency infliximab: A novel treatment paradigm for hidradenitis suppurativa"

Authors

Madeline Adelman
Alexis B. Lyons, Henry Ford HealthFollow
Iltefat H. Hamzavi, Henry Ford HealthFollow

Recommended Citation

Adelman M, Lyons AB, Hamzavi IH. Comment on "High-dose, high-frequency infliximab: A novel treatment paradigm for hidradenitis suppurativa". Journal of the American Academy of Dermatology 2020.

Document Type

Article

Publication Date

11-27-2020

Publication Title

Journal of the American Academy of Dermatology

PubMed ID

33253840